Immunis logo

Immunis Funding & Investors

Immunis a private biotechnology company developing a novel treatment for age and disease-related immune decline.

immunisbiomedical.com

Total Amount Raised: $25,793,916

Immunis Funding Rounds

  • Series Unknown

    $15,793,916

  • Series A

    $10,000,000

    Series A Investors

    Remiges Ventures
    Continuum Health Ventures
Funding info provided by Diffbot.